Investment Rating - The report does not explicitly state an investment rating for the civil drone industry, but it indicates a positive outlook for growth and development in the sector [4][28]. Core Insights - The civil drone industry in China is experiencing significant growth driven by policy and technological advancements, with a projected market size exceeding 680 billion yuan by 2030 and a compound annual growth rate (CAGR) of 28.6% [28][29]. - The demand for industrial drones is increasing, with applications in agriculture, surveying, and inspection, while the consumer drone market continues to expand due to a stable customer base [4][5][29]. - Major players in the industrial drone market include DJI, Zongheng, and Guandian Defense, which hold competitive advantages in technology and scale [5][15][16]. Summary by Sections Industrial Drone Market - The industrial drone market is characterized by various segments, including agriculture, surveying, and inspection, which have shown significant growth in recent years [5][12]. - The use of industrial drones leads to substantial cost savings and efficiency improvements, with efficiency gains of over 10% in agriculture and up to 90% cost savings in surveying compared to traditional methods [12][16]. - Key competitors in the industrial drone sector include DJI, Zongheng, and Guandian Defense, which leverage their technological and operational advantages to maintain market leadership [15][16]. Consumer Drone Market - The consumer drone market is segmented into toy-grade, entry-level, and mid-to-high-end drones, with mid-range drones holding the largest market share at 35% [22][26]. - DJI dominates the consumer drone market, accounting for approximately 70% of the entry-level segment and 53.3% of the mid-to-high-end segment in 2023 [26][28]. - The toy-grade segment is also significant, with brands like DJI Tello leading in sales, although some models have been discontinued [26][22]. Market Size and Growth Projections - The civil drone market in China is expected to grow rapidly, with projections indicating a market size exceeding 680 billion yuan by 2030, driven by the expansion of the low-altitude economy [28][29]. - The industrial drone market share is anticipated to increase from 55% in 2021 to 65.3% in 2022, with further growth expected as applications in various sectors expand [29].

Investment Rating - The report does not explicitly provide an investment rating for the industry Core Insights - The Southeast Asian market has become a crucial strategic direction for Chinese goods to expand internationally, driven by rapid economic development in both China and Southeast Asia, as well as the implementation of the Belt and Road Initiative [6][10] - The industry is characterized by a diverse export structure, with a strong growth trend in high-tech products, although they currently represent a smaller share of total exports [10][23] - The market size of the industry has grown from approximately $31.91 billion in 2018 to $52.19 billion in 2023, with a compound annual growth rate (CAGR) of 10.34% [32] Summary by Sections Industry Definition - The industry refers to the economic activities and processes involved in exporting Chinese-produced goods to Southeast Asia, covering all aspects from product design to after-sales service [5][6] Industry Classification - The industry can be classified based on business models, including direct sales, distributor models, agency models, and e-commerce sales [7][8] Industry Characteristics - The export of Chinese goods to Southeast Asia is dominated by electromechanical products, which accounted for 40% of exports from 2019 to 2023, while high-tech products saw an average annual growth rate exceeding 10% [10][11] - Labor-intensive products represented 19.03% of exports in 2023, indicating a trend of structural upgrade in China's industry [10] Development History - The industry has evolved through five stages: 1. The embryonic stage (1900-1980) characterized by limited growth 2. The initiation stage (1980-1991) marked by rapid growth due to reforms 3. The high-speed development stage (1992-2007) following China's WTO accession 4. The turbulence stage (2008-2015) impacted by the global financial crisis 5. The maturity stage (2016-present) with deepened economic cooperation and diversified product structures [14][15] Industry Chain Analysis - The industry chain consists of upstream raw material supply, midstream manufacturing, and downstream sales, with a focus on local production and market responsiveness [21][26] - The relationship between China and Southeast Asia is characterized by both competition and cooperation, particularly in labor-intensive sectors [22] Market Size - The market size is projected to grow from approximately $56.32 billion in 2024 to $76.33 billion by 2028, with a CAGR of 7.90% [32] Policy Overview - Policies have been implemented to support the stable development of foreign trade, enhancing the role of cross-border e-commerce and improving trade efficiency [37]

Investment Rating - The industry rating for ginseng health food is 4 stars [25] Core Insights - Ginseng health food is categorized under traditional Chinese medicine and is expected to see continuous market expansion due to favorable policies and increasing demand from the aging population [4][7][24] - The market size of ginseng health food grew from 10.415 billion RMB in 2019 to 12.139 billion RMB in 2023, with a compound annual growth rate (CAGR) of 3.90%. It is projected to reach 15.104 billion RMB by 2028, with a CAGR of 4.70% [23][24] Industry Definition - Ginseng health food refers to health products primarily made from ginseng, a valuable resource in traditional Chinese medicine known for its various health benefits [5][6] Industry Classification - Ginseng health food can be classified into several dosage forms, including capsules, oral liquids, tinctures, and tablets, with capsules being the most common [6] Industry Characteristics - The industry is characterized by favorable policies supporting traditional Chinese medicine, a growing number of participants, and a rich resource base of ginseng [7][8][10] Development History - The industry has evolved through three stages: the budding phase (1970-1999), the rapid development phase (2000-2015), and the maturity phase (2016-2024), with significant regulatory improvements and technological advancements [11][12][14] Supply Chain Analysis - The supply chain consists of upstream raw material suppliers, midstream manufacturers, and downstream sales channels, with ginseng health wine emerging as a popular product type [15][19] Market Size - The market size for ginseng health food is expected to continue expanding due to increased production, favorable policies, and rising health awareness among consumers [23][24] Policy Overview - Recent policies have facilitated the entry of traditional Chinese medicine into the health food sector, with ginseng officially included in the health food raw material directory as of May 2024 [24][28] Competitive Landscape - The competitive landscape is tiered, with leading companies like Tongrentang and Kangmei Pharmaceutical dominating the market, leveraging their deep integration within the traditional Chinese medicine industry [33][34]

Investment Rating - The report does not explicitly state an investment rating for the pericarditis drug industry in China Core Insights - The pericarditis drug market in China is projected to grow from 22.2 billion RMB in 2022 to 30.63 billion RMB by 2027, reflecting a compound annual growth rate (CAGR) of approximately 7.85% [15][19] - The incidence rate of pericarditis is expected to increase from 4.79% in 2020 to 5.38% by 2027, indicating a growing patient population [19][21] - The average annual drug cost for pericarditis patients is projected to decrease from 0.03 million RMB in 2022 to 0.02 million RMB by 2027, suggesting cost containment measures or changes in treatment protocols [21][23] Market Size Overview - The market size for pericarditis drugs in China from 2017 to 2027 is as follows: - 2017: 12.29 billion RMB - 2018: 13.81 billion RMB - 2019: 15.09 billion RMB - 2020: 16.48 billion RMB - 2021: 18.22 billion RMB - 2022: 20.08 billion RMB - 2023E: 21.62 billion RMB - 2024E: 26.25 billion RMB - 2025E: 28.4 billion RMB - 2026E: 30.63 billion RMB - 2027E: 30.63 billion RMB [15][19] Population and Incidence Rate - The total population in China is projected to remain relatively stable, with slight increases from 141,175 million in 2022 to 142,348 million by 2027 [17] - The incidence rate of pericarditis is expected to rise steadily, with a notable increase from 4.9% in 2023E to 5.38% in 2027E [19][21] Drug Penetration Rate - The penetration rate of pericarditis drugs is anticipated to grow from 9.11% in 2022 to 23.12% by 2027, indicating an increasing adoption of treatment options [23] Average Drug Costs - The average annual drug cost for pericarditis is projected to decrease from 0.03 million RMB in 2022 to 0.02 million RMB by 2027, reflecting potential changes in treatment strategies or drug pricing [21][23]

Industry Investment Rating - The report does not explicitly mention an investment rating for the industry [1][2][3] Core Views - The medical device industry is undergoing high-quality development, driven by domestic substitution and technological innovation [3] - The 18A rule has provided a platform for excellent medical device companies to grow, enhancing industry vitality [3] - Centralized procurement and healthcare payment reforms are accelerating market consolidation and promoting cost-effective solutions [3] - The vascular interventional device market is growing steadily, with a total transaction volume of 21,0755 units in 2023, and a 39.3% share in Q4 [4] - The non-vascular interventional device market is expanding, with global procedures increasing from 77.1 million in 2016 to 125.1 million in 2022, and expected to reach 256.2 million by 2030 [5] - The in-vitro diagnostics (IVD) market is dominated by molecular diagnostics, immunodiagnostics, and biochemical diagnostics, with immunodiagnostics being the largest segment [6] Market Conditions by Category Vascular Interventional Devices - The vascular interventional device market saw a total transaction volume of 21,0755 units in 2023, with Q4 accounting for 39.3% of the total [4] - The total transaction amount was 14.3 billion, with Q2 accounting for 31.0% [4] Non-Vascular Interventional Devices - Global non-vascular interventional procedures increased from 77.1 million in 2016 to 125.1 million in 2022, and are expected to reach 256.2 million by 2030 [5] - In China, non-vascular interventional procedures grew from 21.1 million in 2016 to 37.6 million in 2022, and are expected to reach 89.0 million by 2030 [5] In-Vitro Diagnostics (IVD) - The IVD market is segmented into molecular diagnostics, immunodiagnostics, and biochemical diagnostics, with immunodiagnostics being the largest segment [6] - Immunodiagnostics, based on immunology principles, includes technologies like chemiluminescence, enzyme-linked immunosorbent assay (ELISA), and colloidal gold [6] Interventional Medical Devices Definition and Classification - Interventional medicine uses imaging diagnostics to guide treatments, involving minimally invasive techniques with small incisions and reduced risks [9][10] - It is divided into vascular and non-vascular interventional medicine, with applications in treating vascular diseases, tumors, and organ dysfunctions [11][12] Industry Chain - The interventional device industry chain includes upstream raw material suppliers, midstream manufacturers, and downstream healthcare institutions [13][14] - Upstream materials include medical polymers and metals, with high dependence on overseas suppliers due to stringent quality requirements [14] - Midstream manufacturers face intense competition, with multinational companies dominating the high-end market, while local companies are making breakthroughs in certain segments [14] Coronary Intervention - PCI (Percutaneous Coronary Intervention) procedures in China increased from 915,000 in 2018 to 1.636 million in 2023, with a CAGR of 12.3% [15][17] - The penetration rate of PCI in China is lower compared to developed countries, with 824.1 procedures per million population in 2021 [16] - The market size for precision PCI in China grew from 510 million in 2019 to 3.93 billion in 2023, with a CAGR of 66.6%, and is expected to reach 8.87 billion by 2028 [19][20] Neurointervention - The neurointerventional device market in China grew from 4.56 billion in 2019 to 8.25 billion in 2023, with a CAGR of 16.0%, and is expected to reach 43.22 billion by 2028 [21] - Factors driving growth include aging populations, supportive policies, and advancements in AI technology for cerebrovascular disease diagnosis and treatment [21] Peripheral Vascular Intervention - The peripheral vascular interventional device market in China grew from 3.26 billion in 2019 to 6.39 billion in 2023, with a CAGR of 18.3%, and is expected to reach 13.24 billion by 2028 [22] - The market is currently dominated by foreign companies, with domestic companies making progress in single-product breakthroughs [22] Non-Vascular Intervention - The global endoscope market for non-vascular interventions grew from 14.4 billion in 2019 to 18.7 billion in 2023, and is expected to reach 27.7 billion by 2028 [24] - In China, the market grew from 17.1 billion in 2019 to 22.8 billion in 2023, and is expected to reach 38.4 billion by 2028 [24] In-Vitro Diagnostics (IVD) Definition and Classification - IVD involves testing human samples outside the body to obtain clinical diagnostic information, with applications in disease prevention, diagnosis, and monitoring [27][28] - The market is segmented into immunodiagnostics, microbiological diagnostics, molecular diagnostics, POCT, biochemical diagnostics, and clinical laboratory diagnostics [29] Industry Chain - The IVD industry chain includes upstream raw material suppliers, midstream manufacturers, and downstream healthcare institutions [30][31] - Upstream materials include diagnostic enzymes, antigens, and antibodies, with high technical barriers and low domestic production rates [31] - Midstream manufacturers focus on R&D, production, and quality control, with international companies dominating the high-end market [33] Market Size - The IVD market in China grew from 1.185 trillion in 2019 to 2.417 trillion in 2023, with a CAGR of 19.5%, and is expected to reach 4.442 trillion by 2028 [34][35] - Key drivers include aging populations, increasing healthcare expenditures, and advancements in technology [35]

Investment Rating - The report indicates a positive investment outlook for the educational instrument manufacturing industry, with a projected compound annual growth rate (CAGR) of 7.70% from 2024 to 2028, following a CAGR of 10.87% from 2018 to 2023 [32]. Core Insights - The educational instrument manufacturing industry is experiencing continuous market growth driven by increased educational investment, expansion of online education users, and growth in the number of compulsory education students. However, challenges such as long equipment update cycles, high entry barriers, and low market efficiency persist [4][11]. - The demand for educational instruments is expected to remain robust due to the ongoing development of China's education sector, with the number of enrolled students increasing from 276 million in 2018 to 293 million in 2023, and total educational funding rising from 4,614.3 billion RMB to 6,134.4 billion RMB during the same period [20][33]. Industry Definition - The educational instrument industry focuses on creating and providing specialized equipment and tools tailored to specific teaching needs across various educational stages and disciplines. This includes a wide range of teaching devices, general instruments, and non-specialized equipment [5]. Industry Characteristics - The educational instrument manufacturing industry is characterized by long equipment update cycles, high entry barriers, and low market efficiency. The average update cycle for educational instruments is 8 to 10 years, and many instruments are used for over a decade before replacement is considered [11][12]. Industry Development History - The educational instrument industry in China has evolved through four stages: initiation (1949-1978), turbulence (1978-1985), rapid growth (1985-2010), and the current phase of information-based balanced development (2010-present). The industry is now moving towards intelligent, personalized, and international development [14][18]. Industry Scale - The market size of the educational instrument manufacturing industry grew from 960 billion RMB in 2018 to 1,600 billion RMB in 2023, with a CAGR of 10.87%. It is projected to reach 2,390 billion RMB by 2028 [32][33]. Policy Overview - Recent policies emphasize the modernization of educational equipment, with significant funding support for updating outdated teaching and research devices. The "Implementation Plan for Major Equipment Updates in the Education Sector" aims to enhance educational quality and research capabilities [38]. Competitive Landscape - The educational instrument manufacturing industry features multiple tiers of companies, with leading firms like China Teaching Instrument Equipment Co., Ltd. and Zhejiang Qiushi Science Education Equipment Co., Ltd. dominating the market. The industry is characterized by regional disparities and a historical prevalence of family-run businesses [42][44].

Investment Rating - The report rates the six-dimensional torque sensor industry with a 4-star rating, indicating a positive outlook for investment opportunities in this sector [32]. Core Insights - The six-dimensional torque sensor is a high-precision measuring instrument with increasing market demand, particularly in high-end equipment manufacturing. The Chinese market is currently dominated by foreign companies, but the pace of domestic production is accelerating, leading to intense competition and high market concentration. The industry has high technical barriers, involving complex production technologies and force control algorithms. Future growth is expected to be driven by the rising demand for humanoid robots and supportive policies, with the market projected to maintain rapid growth from 2025 to 2028 [4][10][32]. Industry Definition - Six-dimensional torque sensors are designed to measure three forces and three torques in three-dimensional space, combining mechanics and electronics to convert physical quantities into electrical signals for high-precision measurement [5]. Industry Characteristics - **Market Demand Growth**: The market demand for six-dimensional torque sensors is robust, driven by the transformation of global manufacturing and advancements in robotics, particularly in smart manufacturing and industrial automation [9][10]. - **Foreign Market Dominance**: Foreign companies currently hold about 70% of the Chinese market share, with domestic manufacturers accounting for approximately 30%. Domestic firms are increasing R&D investments to improve product quality and competitiveness [10][43]. - **High Entry Barriers**: The industry has high technical difficulty across all stages, requiring advanced manufacturing processes and significant capital investment [11]. - **Intense Competition**: The market is characterized by high concentration, with a few companies holding significant market shares. The competition is expected to intensify as domestic brands improve their capabilities [12][43]. Development History - The six-dimensional torque sensor industry has evolved through three stages: inception (1974-1990), initiation (1990-2020), and rapid development (2020-present). The current phase is marked by significant demand growth, particularly in robotics and industrial automation [13][16]. Industry Chain Analysis - **Upstream**: The upstream segment includes raw materials and component manufacturing, which directly impacts the performance of the sensors. Key materials include strain gauges and elastic bodies [17][18]. - **Midstream**: The midstream focuses on the manufacturing of six-dimensional torque sensors, where precision in assembly and testing is crucial [24]. - **Downstream**: The downstream applications span various industries, including industrial robotics, humanoid robots, aerospace, and medical fields, with humanoid robots expected to drive significant future demand [27][28]. Market Size - The market size for the six-dimensional torque sensor industry is projected to grow from 0.81 billion RMB in 2019 to 14.74 billion RMB by 2025, with a compound annual growth rate (CAGR) of 62.27%. From 2026 to 2028, the market is expected to expand from 24.28 billion RMB to 70.28 billion RMB, with a CAGR of 70.12% [32]. Competitive Landscape - The competitive landscape is characterized by a few leading companies, with the top 10 firms holding nearly 70% of the market share. Key players include ATI, Yuli Instruments, and Kunwei Technology, with domestic brands gradually closing the gap with international competitors [43][44].

Investment Rating - The report does not explicitly state an investment rating for the self-emissive display panel industry Core Insights - The self-emissive display panel market in China is projected to grow from CNY 1,653.8 billion in 2022 to CNY 2,646.02 billion by 2027, reflecting a compound annual growth rate (CAGR) of approximately 9.44% [22][31] - The OLED display panel market is expected to see significant growth, with the market size increasing from CNY 641.3 billion in 2022 to CNY 861.62 billion by 2027, indicating a CAGR of about 4.47% [31][28] - The LED display panel market is forecasted to recover from a decline in 2022, with an expected growth from CNY 1,012.5 billion in 2022 to CNY 1,784.4 billion by 2027, achieving a steady CAGR of 12% [22][38] Summary by Sections 1. Market Size Overview - The self-emissive display panel market in China is projected to reach CNY 1,856.89 billion in 2023, with a growth rate of 12.28% compared to the previous year [22] - The OLED segment is expected to grow significantly, with a forecast of CNY 722.89 billion in 2023, marking a growth rate of 12.72% [31] - The LED segment is anticipated to grow to CNY 1,134 billion in 2023, with a growth rate of 12% [38] 2. Global AMOLED Display Panel Shipment - Global shipments of AMOLED display panels are projected to increase from 922 million units in 2022 to 1,144 million units by 2027, with a steady growth rate of around 4.38% [23] 3. PMOLED Display Panel Global Market Size - The PMOLED market is expected to grow from USD 255 million in 2022 to USD 411 million by 2027, with a CAGR of approximately 9.89% [24] 4. Global OLED Display Panel Market Size - The global OLED display panel market is projected to grow from USD 9,625 million in 2017 to USD 23,291 million by 2027, reflecting a CAGR of about 4.47% [26] 5. China's OLED Display Panel Market Size - The Chinese OLED display panel market is expected to grow from USD 48.13 million in 2017 to USD 12,810.05 million by 2027, with a significant growth rate of 4.47% [31] 6. Exchange Rate Impact - The USD to CNY exchange rate is projected to remain stable around 6.73 from 2023 to 2027, which may impact the pricing and competitiveness of imported display panels [30]

Investment Rating - The report does not explicitly state an investment rating for the cardiovascular health food industry in China Core Insights - The cardiovascular health food industry in China is experiencing rapid growth driven by an aging population and increasing health awareness among consumers. The potential for growth in cardiovascular health food products is expected to be rapidly released with policy support [3][6] - The demand for cardiovascular health food products is rising as the public becomes more aware of the health risks associated with hypertension, hyperlipidemia, and hyperglycemia, which are major risk factors for cardiovascular diseases [4][18] - The industry is characterized by a dual-track registration and filing system for health food products, which enhances the flexibility of new product launches and standardizes the industry [21][23] Summary by Sections Industry Overview - Cardiovascular diseases, including coronary heart disease and stroke, are prevalent, with "three highs" (hypertension, hyperlipidemia, and hyperglycemia) being significant risk factors [15][16] - The industry has evolved from disorderly to orderly, with improved regulatory frameworks and market standardization, currently in a phase of high-quality development [21][22] Market Size - The market size for cardiovascular health food products in China grew from 142.56 billion yuan in 2019 to 158.39 billion yuan in 2023, with projections to reach 189.89 billion yuan by 2028 [27][28] - The middle-aged and elderly markets are expanding due to increased health awareness and the aging population, respectively [26][29] Industry Chain Analysis - The industry chain consists of upstream raw material suppliers, midstream manufacturers, and downstream sales channels [33] - Traditional Chinese medicine is recognized as a significant source of raw materials for cardiovascular health products, with ingredients like ginseng, astragalus, and hawthorn being commonly used [36][38] Competitive Landscape - The industry is competitive, with a low concentration of market share and significant product homogeneity. Companies compete on product quality, innovation, brand building, and market positioning [46][47] - The growth potential of companies in this sector is influenced by their ability to innovate and control costs effectively [47]

| --- | --- | --- | |--------|------------------|-------| | | | | | 2024年 | 头豹行业词条报告 | | Leadleo.com 工业级海绵锆：高性能材料，铸就石油化工安全基 石 头豹词条报告系列 孙越 · 头豹分析师 2024-08-23 未经平台授权，禁止转载 孙 行业： 制造业/有色金属冶炼和压延加工业/有色金属压延加工 原材料业/一般金属 版权有问题？点此投诉 | --- | --- | --- | --- | --- | --- | --- | |----------|--------------------------------------------------------------------------|----------|---------------------------------------------------------------------------------|------------------------------------------------------------------ ...